Minaris (WuXi Advanced Therapies)

Philadelphia, PA / Yokohama, Japan
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
60.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Minaris (WuXi Advanced Therapies)

Signal Score
60.5/100 (as of 2026-04-02)
Quality Compliance
Assessment pending
Headquarters
Philadelphia, PA / Yokohama, Japan
Modalities
CAR-T, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesCAR-T, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 58.0
BIOSECURE Act exposure risk
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
BIOSECURE Act exposure risk
Capacity 63.0
3 manufacturing sites
Sites: Philadelphia, PA, Yokohama, Japan, Shanghai, China
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
3 manufacturing sites
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.5
CAR-T, Cell Therapy
GenScript
Piscataway, NJ / Nanjing, China
Signal Score: 65.5
CAR-T, Cell Therapy, Gene Editing
Hitachi Global Life Solutions (CGT)
Yokohama, JP
Signal Score: 63.0
Cell Therapy, CAR-T
NegotiumBio LLC & GmbH
Basel, Switzerland (GmbH) / Greater Boston, MA (LLC)
Small Molecules, Biologics, Cell Therapy, Gene Therapy, CAR-T, Viral Vectors, Oligonucleotides
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral